Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

V K Ghanta

Showing results (1-10 of 96) with videos related to

Pageof 10
Sort By:
International Journal of Cancer|March 15, 1980
Surgical adjuvant chemotherapy of metastatic murine osteosarcomaR N Hiramoto, V K Ghanta
Journal of Oral Pathology|May 1, 1977
Autoimmune disease antigensR N Hiramoto, V K Ghanta
Cancer Research|July 1, 1974
Chemotherapy and rate of kill of tumor cells in a mouse plasmacytomaR N Hiramoto, V K Ghanta
Journal of Immunology (Baltimore, Md. : 1950)|September 1, 1973
Studies of MOPC 104E plasmacytoma cells forming rosettes with autologous and syngeneic erythrocytesR N Hiramoto, V K Ghanta
Journal of the National Cancer Institute|April 1, 1974
Quantitation of total-body tumor cells (MOPC 104E). I. Subcutaneous tumor modelV K Ghanta, R N Hiramoto
Immunochemistry|June 1, 1974
Quantitation of antigens by immunoelectrophoresisV K Ghanta, R N Hiramoto
International Journal of Cancer|June 15, 1984
Regulation of MOPC 104E by T cells and growth factors induced by C. parvum stimulationK Shrestha, R N Hiramoto, V K Ghanta
Cellular Immunology|January 1, 1985
Establishment of growth factor-dependent MOPC 104E cell line in vitroK Shrestha, R N Hiramoto, V K Ghanta
Cancer Investigation|January 1, 1990
Host response to myeloma: effect of syngeneic spleen cells on the growth and function of MOPC 104E myeloma in vitroT Miura, V K Ghanta, R N Hiramoto
American Journal of Clinical Oncology|February 1, 1983
Investigation in the role of surgery, chemotherapy, and radiation in a murine osteosarcoma modelR N Hiramoto, Y Kikuchi, V K Ghanta
Pageof 10

Showing results (1-10 of 96) with videos related to

Sort By:
Pageof 10
International Journal of Cancer|March 15, 1980
Surgical adjuvant chemotherapy of metastatic murine osteosarcomaR N Hiramoto, V K Ghanta
Journal of Oral Pathology|May 1, 1977
Autoimmune disease antigensR N Hiramoto, V K Ghanta
Cancer Research|July 1, 1974
Chemotherapy and rate of kill of tumor cells in a mouse plasmacytomaR N Hiramoto, V K Ghanta
Journal of Immunology (Baltimore, Md. : 1950)|September 1, 1973
Studies of MOPC 104E plasmacytoma cells forming rosettes with autologous and syngeneic erythrocytesR N Hiramoto, V K Ghanta
Journal of the National Cancer Institute|April 1, 1974
Quantitation of total-body tumor cells (MOPC 104E). I. Subcutaneous tumor modelV K Ghanta, R N Hiramoto
Immunochemistry|June 1, 1974
Quantitation of antigens by immunoelectrophoresisV K Ghanta, R N Hiramoto
International Journal of Cancer|June 15, 1984
Regulation of MOPC 104E by T cells and growth factors induced by C. parvum stimulationK Shrestha, R N Hiramoto, V K Ghanta
Cellular Immunology|January 1, 1985
Establishment of growth factor-dependent MOPC 104E cell line in vitroK Shrestha, R N Hiramoto, V K Ghanta
Cancer Investigation|January 1, 1990
Host response to myeloma: effect of syngeneic spleen cells on the growth and function of MOPC 104E myeloma in vitroT Miura, V K Ghanta, R N Hiramoto
American Journal of Clinical Oncology|February 1, 1983
Investigation in the role of surgery, chemotherapy, and radiation in a murine osteosarcoma modelR N Hiramoto, Y Kikuchi, V K Ghanta
Pageof 10